Cargando…

Derivation and Validation of a Prognostic Model for Cancer Dependency Genes Based on CRISPR-Cas9 in Gastric Adenocarcinoma

As a CRISPR-Cas9-based tool to help scientists to investigate gene functions, Cancer Dependency Map genes (CDMs) include an enormous series of loss-of-function screens based on genome-scale RNAi. These genes participate in regulating survival and growth of tumor cells, which suggests their potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Wenjie, Li, Junqing, Lu, Xiaofang, Liu, Fangjie, An, Tailai, Xiao, Xing, Kuo, Zi Chong, Wu, Wenhui, He, Yulong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959733/
https://www.ncbi.nlm.nih.gov/pubmed/33732644
http://dx.doi.org/10.3389/fonc.2021.617289
_version_ 1783665013988261888
author Zhou, Wenjie
Li, Junqing
Lu, Xiaofang
Liu, Fangjie
An, Tailai
Xiao, Xing
Kuo, Zi Chong
Wu, Wenhui
He, Yulong
author_facet Zhou, Wenjie
Li, Junqing
Lu, Xiaofang
Liu, Fangjie
An, Tailai
Xiao, Xing
Kuo, Zi Chong
Wu, Wenhui
He, Yulong
author_sort Zhou, Wenjie
collection PubMed
description As a CRISPR-Cas9-based tool to help scientists to investigate gene functions, Cancer Dependency Map genes (CDMs) include an enormous series of loss-of-function screens based on genome-scale RNAi. These genes participate in regulating survival and growth of tumor cells, which suggests their potential as novel therapeutic targets for malignant tumors. By far, studies on the roles of CDMs in gastric adenocarcinoma (GA) are scarce and only a small fraction of CDMs have been investigated. In the present study, datasets of the differentially expressed genes (DEGs) were extracted from the TCGA-based (The Cancer Genome Atlas) GEPIA database, from which differentially expressed CDMs were determined. Functions and prognostic significance of these verified CDMs were evaluated using a series of bioinformatics methods. In all, 246 differentially expressed CDMs were determined, with 147 upregulated and 99 downregulated. Ten CDMs (ALG8, ATRIP, CCT6A, CFDP1, CINP, MED18, METTL1, ORC1, TANGO6, and PWP2) were identified to be prognosis-related and subsequently a prognosis model based on these ten CDMs was constructed. In comparison with that of patients with low risk in TCGA training, testing and GSE84437 cohort, overall survival (OS) of patients with high risk was significantly worse. It was then subsequently demonstrated that for this prognostic model, area under the ROC (receiver operating characteristic) curve was 0.771 and 0.697 for TCGA training and testing cohort respectively, justifying its reliability in predicting survival of GA patients. With the ten identified CDMs, we then constructed a nomogram to generate a clinically practical model. The regulatory networks and functions of the ten CDMs were then explored, the results of which demonstrated that as the gene significantly associated with survival of GA patients and Hazard ratio (HR), PWP2 promoted in-vitro invasion and migration of GA cell lines through the EMT signaling pathway. Therefore, in conclusion, the present study might help understand the prognostic significance and molecular functions of CDMs in GA.
format Online
Article
Text
id pubmed-7959733
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79597332021-03-16 Derivation and Validation of a Prognostic Model for Cancer Dependency Genes Based on CRISPR-Cas9 in Gastric Adenocarcinoma Zhou, Wenjie Li, Junqing Lu, Xiaofang Liu, Fangjie An, Tailai Xiao, Xing Kuo, Zi Chong Wu, Wenhui He, Yulong Front Oncol Oncology As a CRISPR-Cas9-based tool to help scientists to investigate gene functions, Cancer Dependency Map genes (CDMs) include an enormous series of loss-of-function screens based on genome-scale RNAi. These genes participate in regulating survival and growth of tumor cells, which suggests their potential as novel therapeutic targets for malignant tumors. By far, studies on the roles of CDMs in gastric adenocarcinoma (GA) are scarce and only a small fraction of CDMs have been investigated. In the present study, datasets of the differentially expressed genes (DEGs) were extracted from the TCGA-based (The Cancer Genome Atlas) GEPIA database, from which differentially expressed CDMs were determined. Functions and prognostic significance of these verified CDMs were evaluated using a series of bioinformatics methods. In all, 246 differentially expressed CDMs were determined, with 147 upregulated and 99 downregulated. Ten CDMs (ALG8, ATRIP, CCT6A, CFDP1, CINP, MED18, METTL1, ORC1, TANGO6, and PWP2) were identified to be prognosis-related and subsequently a prognosis model based on these ten CDMs was constructed. In comparison with that of patients with low risk in TCGA training, testing and GSE84437 cohort, overall survival (OS) of patients with high risk was significantly worse. It was then subsequently demonstrated that for this prognostic model, area under the ROC (receiver operating characteristic) curve was 0.771 and 0.697 for TCGA training and testing cohort respectively, justifying its reliability in predicting survival of GA patients. With the ten identified CDMs, we then constructed a nomogram to generate a clinically practical model. The regulatory networks and functions of the ten CDMs were then explored, the results of which demonstrated that as the gene significantly associated with survival of GA patients and Hazard ratio (HR), PWP2 promoted in-vitro invasion and migration of GA cell lines through the EMT signaling pathway. Therefore, in conclusion, the present study might help understand the prognostic significance and molecular functions of CDMs in GA. Frontiers Media S.A. 2021-02-25 /pmc/articles/PMC7959733/ /pubmed/33732644 http://dx.doi.org/10.3389/fonc.2021.617289 Text en Copyright © 2021 Zhou, Li, Lu, Liu, An, Xiao, Kuo, Wu and He http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhou, Wenjie
Li, Junqing
Lu, Xiaofang
Liu, Fangjie
An, Tailai
Xiao, Xing
Kuo, Zi Chong
Wu, Wenhui
He, Yulong
Derivation and Validation of a Prognostic Model for Cancer Dependency Genes Based on CRISPR-Cas9 in Gastric Adenocarcinoma
title Derivation and Validation of a Prognostic Model for Cancer Dependency Genes Based on CRISPR-Cas9 in Gastric Adenocarcinoma
title_full Derivation and Validation of a Prognostic Model for Cancer Dependency Genes Based on CRISPR-Cas9 in Gastric Adenocarcinoma
title_fullStr Derivation and Validation of a Prognostic Model for Cancer Dependency Genes Based on CRISPR-Cas9 in Gastric Adenocarcinoma
title_full_unstemmed Derivation and Validation of a Prognostic Model for Cancer Dependency Genes Based on CRISPR-Cas9 in Gastric Adenocarcinoma
title_short Derivation and Validation of a Prognostic Model for Cancer Dependency Genes Based on CRISPR-Cas9 in Gastric Adenocarcinoma
title_sort derivation and validation of a prognostic model for cancer dependency genes based on crispr-cas9 in gastric adenocarcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959733/
https://www.ncbi.nlm.nih.gov/pubmed/33732644
http://dx.doi.org/10.3389/fonc.2021.617289
work_keys_str_mv AT zhouwenjie derivationandvalidationofaprognosticmodelforcancerdependencygenesbasedoncrisprcas9ingastricadenocarcinoma
AT lijunqing derivationandvalidationofaprognosticmodelforcancerdependencygenesbasedoncrisprcas9ingastricadenocarcinoma
AT luxiaofang derivationandvalidationofaprognosticmodelforcancerdependencygenesbasedoncrisprcas9ingastricadenocarcinoma
AT liufangjie derivationandvalidationofaprognosticmodelforcancerdependencygenesbasedoncrisprcas9ingastricadenocarcinoma
AT antailai derivationandvalidationofaprognosticmodelforcancerdependencygenesbasedoncrisprcas9ingastricadenocarcinoma
AT xiaoxing derivationandvalidationofaprognosticmodelforcancerdependencygenesbasedoncrisprcas9ingastricadenocarcinoma
AT kuozichong derivationandvalidationofaprognosticmodelforcancerdependencygenesbasedoncrisprcas9ingastricadenocarcinoma
AT wuwenhui derivationandvalidationofaprognosticmodelforcancerdependencygenesbasedoncrisprcas9ingastricadenocarcinoma
AT heyulong derivationandvalidationofaprognosticmodelforcancerdependencygenesbasedoncrisprcas9ingastricadenocarcinoma